AbbVie Inc. and Cerevel Therapeutics Holdings, Inc. merger | Practical Law
AbbVie Inc. and Cerevel Therapeutics Holdings, Inc. merger
Enter to open, tab to navigate, enter to select
US Home
Global Home
NEW
Sign in
Sign in
All content
Search:
Search Westlaw
Search Tips
Advanced
AbbVie Inc. and Cerevel Therapeutics Holdings, Inc. merger
AbbVie Inc. and Cerevel Therapeutics Holdings, Inc. merger
December 06, 2023
•
Public Merger Agreements
•
$8.7 billion (equity value disclosed by the parties).
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.
Back to top